SPARC and hyperphosphatemia: In vitro experiments show that osteocalcin (bone–Gla protein), osteonectin, and an elevated rate of osteopontin, induced by hyperphosphatemia, may have an inhibitory effect on matrix mineralization by binding to lattice calcium exposed at the crystal surfaces, regulating crystal dimensions [43].